| Sierra Corbin, | |
|
101 Branigin Blvd, Franklin, IN 46131-2598 | |
| (800) 852-0232 | |
| Not Available |
| Full Name | Sierra Corbin |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 101 Branigin Blvd, Franklin, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336724434 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sierra Corbin, 421 Azalea Dale Dr, Chattanooga, TN 37419-2155 Ph: () - | Sierra Corbin, 101 Branigin Blvd, Franklin, IN 46131-2598 Ph: (800) 852-0232 |
News Archive
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
Resting cancer cells can be selectively destroyed by inhibiting their energy metabolism. This is the recent discovery by researchers at Charité Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine (MDC) in Berlin-Buch, together with other cooperation partners from Germany. The findings of their study have been published in the scientific journal Nature.
According to the latest research five simple lifestyle changes could cut the risk of bowel cancer by 23%. The Danish study enrolled 57,053 adults aged 50 to 64 without cancer between 1993 and 1997. They were followed up closely for 10 years. Results showed that people who followed public health recommendations (not smoking, a healthier diet, etc.) for each of these areas had a lower risk of developing colorectal cancer during this time.
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
Has tooth brushing frequency improved among children and adolescents? At what age is occupational therapy most commonly used? How many girls have been vaccinated against Human papillomavirus (HPV)? What influence does social status have on the utilization of medical services?
› Verified 6 days ago
Amy Lynn Purol, MPAS, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1125 W Jefferson St, Franklin, IN 46131 Phone: 317-736-2601 | |
Thomas Paul Meehan, PHD, PAC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1125 W Jefferson St, Franklin, IN 46131 Phone: 317-736-2600 | |
Jesse Wakefield Sharp, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1125 W Jefferson St, Franklin, IN 46131 Phone: 317-736-3300 | |
Megana Bammidi, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2085 Acorn Blvd, Franklin, IN 46131 Phone: 317-738-8095 | |
Kelly Ann Orze, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2085 Acorn Blvd, Franklin, IN 46131 Phone: 317-738-8095 | |
Brenna Lee, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1125 W Jefferson St, Franklin, IN 46131 Phone: 317-736-3485 |